Profile
| Metric | Value |
|---|---|
| Full Name | TransMedics Group, Inc. |
| Ticker | NASDAQ: TMDX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | transmedics.com |
| Employees | 728 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $122.69 | |
| Price, 1D Change | +0.85% | |
| Market Cap | $4B | |
| - | ||
| PE Ratio | 49.56 | |
| Beta | 1.17 | |
| Revenue | $442M | |
| Revenue, 1Y Change | +82.74% | |
| EPS | $1.01 | |
| EPS, 1Y Change | +230.83% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $1.01 | |
| EPS Estimate | $2.58 | |
| EPS Est. Change | +156.31% | |
| Revenue | $441.54M | |
| Revenue Estimate | $600.87M | |
| Revenue Est. Change | +36.09% | |
| Current Price | $122.69 | |
| Price Target | - | $148.00 |
| Price Tgt. Change | - | +20.63% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.93 | -$0.77 | +17.24% | |
| $0.97 | $1.01 | +4.35% | |
| $2.58 | N/A | +156.31% | |
| $2.91 | N/A | +189.34% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $228.46M | $241.62M | +5.76% | |
| $429.51M | $441.54M | +2.80% | |
| $600.87M | N/A | +36.09% | |
| $725.09M | N/A | +64.22% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +84.50% | |
| Price, 3Y | +98.78% | |
| Market Cap, 1Y | +87.55% | |
| Market Cap, 3Y | +111.36% | |
| Revenue, 1Y | +82.74% | |
| Revenue, 3Y | +1,359.06% | |
| EPS, 1Y | +230.83% | |
| EPS, 3Y | +162.90% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $122.69 | |
| SMA 200 | $115.40 | |
| SMA 200 vs Price | -5.94% | |
| SMA 50 | $128.62 | |
| SMA 50 vs Price | +4.83% | |
| Beta | 1.17 | |
| ATR | $5.60 | |
| 14-Day RSI | 42.98 | |
| 10-Day Volatility | 33.83% | |
| 1-Year Volatility | 59.89% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $441.54M | |
| EPS | $1.01 | |
| Gross Profit | $262.08M | |
| Gross Margin | 59.36% | |
| Operating Profit | $37.50M | |
| Operating Margin | 8.49% | |
| Net Income | $35.46M | |
| Net Margin | 8.03% | |
| EBITDA | $69.95M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 2.27 | |
| Current Ratio | 8.30 | |
| Quick Ratio | 7.52 | |
| Interest Coverage | 3.48 | |
| F-Score | 7 | |
| Altman Z-Score | 4.77 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 49.56 | |
| PS Ratio | 7.40 | |
| PB Ratio | 11.80 | |
| EV/EBITDA | 34.99 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $228.60M | |
| Cash & Equivalents | $336.65M | |
| Total Assets | $828.43M | |
| Current Assets | $497.22M | |
| Total Liabilities | $599.83M | |
| Current Liabilities | $59.91M | |
| Total Debt | $518.29M | |
| Short Term Debt | $2.73M | |
| Accounts Payable | $10.29M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $404.04M | |
| Operating Expenses | $224.59M | |
| Cost Of Goods Sold | $179.46M | |
| SG&A | $168.62M | |
| D&A | $19.76M | |
| Interest Expense | $14.41M | |
| Income Tax | $316.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $48.80M | |
| CFI | -$129.30M | |
| CFF | $22.87M | |
| Capex | $129.74M | |
| Free Cash Flow | -$80.94M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Canaccord Genuity | → | |
| Needham | → | |
| Morgan Stanley | → | |
| Piper Sandler | → | |
| Canaccord Genuity | → | |
| Needham | → | |
| Canaccord Genuity | → | |
| Jefferies | ||
| Evercore ISI Group | ||
| Stifel |
Analyst sentiment
Institutional ownership
Screeners with TMDX
Data Sources & References
- TMDX Official Website www.transmedics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1756262/000119312525256377/0001193125-25-256377-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1756262/000095017025029104/0000950170-25-029104-index.htm
- TMDX Profile on Yahoo Finance finance.yahoo.com/quote/TMDX
- TMDX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tmdx
FAQ
What is the ticker symbol for TransMedics Group, Inc.?
The ticker symbol for TransMedics Group, Inc. is NASDAQ:TMDX
Does TransMedics Group, Inc. pay dividends?
No, TransMedics Group, Inc. does not pay dividends
What sector is TransMedics Group, Inc. in?
TransMedics Group, Inc. is in the Healthcare sector
What industry is TransMedics Group, Inc. in?
TransMedics Group, Inc. is in the Medical Devices industry
What country is TransMedics Group, Inc. based in?
TransMedics Group, Inc. is headquartered in United States
When did TransMedics Group, Inc. go public?
TransMedics Group, Inc. initial public offering (IPO) was on May 2, 2019
Is TransMedics Group, Inc. in the S&P 500?
No, TransMedics Group, Inc. is not included in the S&P 500 index
Is TransMedics Group, Inc. in the NASDAQ 100?
No, TransMedics Group, Inc. is not included in the NASDAQ 100 index
Is TransMedics Group, Inc. in the Dow Jones?
No, TransMedics Group, Inc. is not included in the Dow Jones index
When was TransMedics Group, Inc. last earnings report?
TransMedics Group, Inc.'s most recent earnings report was on October 29, 2025
When does TransMedics Group, Inc. report earnings?
The next expected earnings date for TransMedics Group, Inc. is February 26, 2026